Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 11 submissions in the queue.
posted by n1 on Thursday December 29 2016, @11:07PM   Printer-friendly
from the your-local-drug-dealers dept.

Six former executives and managers from Arizona-based drugmaker, Insys Therapeutics, face conspiracy charges over what a federal prosecutor calls a "racketeering crime." In this case, according to the indictment, the former employees of the drug manufacturer are alleged to have rewarded doctors for prescribing their spray version of the opiate fentanyl, even when it wasn't medically appropriate.

[...] Three years ago on CNBC, Michael Babich demonstrated the company's drug, "Subsys," a prescription pain reliever for cancer patients which is delivered through a spray. The medication, which the company first sold in 2012, racked up $329 milllion in sales last year. "The device that I brought with me today allows the patient to simply with no priming spray the drug underneath their tongue," Babich explained.

According to the indictment, the defendants "conspired with one another to use bribes and kickbacks" for doctors who "wrote large numbers of... prescriptions, most often for patients who did not have cancer." The scheme allegedly funneled tens or even hundreds of thousands of dollars to practitioners, including one whom a sales representative boasted in an email was running "a very shady pill mill and only accepts cash."

Source: CBS News


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 3, Interesting) by Runaway1956 on Friday December 30 2016, @02:50AM

    by Runaway1956 (2926) Subscriber Badge on Friday December 30 2016, @02:50AM (#447250) Journal

    FFS, with drugs, doctors all over the US are given kickbacks for pushing certain brands. My own doctor gets a little bit of that kickback. He'll admit, if you ask him, that he does push a little. The people with money, and crazy expectations of drugs come in, and insist on this or that advertised miracle drug. He'll sell them the drugs they beg for, and he gets a little money back. Not the kind of money he could get, if he really got to pushing, though.

    Raise your hands - how many of you have been given a specially wrapped for doctor's office use only drug at some point in time? In it's simplest form that is a bribe right there. The salesman gave the doctor 10, 50, or 100 samples of the shit to give away, to induce the doctor to buy and push those drugs. Cash money need not even change hands - you push xxx pills per month, we'll give you yy% discount on your supplies. At it's worst, cash money does change hands. A good pusher - err, doctor - can make thousands per month.

    There's a lot of money in drugs, and accountability isn't nearly strict enough.

    --
    “I have become friends with many school shooters” - Tampon Tim Walz
    Starting Score:    1  point
    Moderation   +1  
       Interesting=1, Total=1
    Extra 'Interesting' Modifier   0  
    Karma-Bonus Modifier   +1  

    Total Score:   3  
  • (Score: 0) by Anonymous Coward on Friday December 30 2016, @04:59AM

    by Anonymous Coward on Friday December 30 2016, @04:59AM (#447290)

    accountability isn't nearly strict enough

    There is a lot of political pressure against government regulation of medical decisions and free speech (about drugs). The pressure comes from all sides: pharmaceutical lobbiests, professional medical societies, small government proponents, left-wing anti vaccine people, right wing anti STD-vaccine people, "right to try" people, and all the people that fall for the "ask your doctor about [drug we're trying to convince you to take]".

    If we can't even get rid of direct-to-patient prescription drug advertising, then how are we going to limit "informational seminars" in Hawaii or invited speeches at conferences in Paris to discuss successful "case studies"?